| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33989390_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33989390_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33989390_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33989390_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/33989390_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33989390_HAS_TOPIC_C5544360> <https://research.tib.eu/covid-19/entity/33989390_HAS_TOPIC_C5544400>
?:authorAffiliation	[\'Division of Pulmonary, Allergy and Critical Care, Emory University School of Medicine, Atlanta, Georgia, USA.\', \'Department of Employee Health, Emory University School of Medicine, Atlanta, Georgia, USA.\', \'Division of Infectious Disease, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Kuruvilla_Merin_Elizabeth> <https://research.tib.eu/covid-19/entity/Lee_Frances_Eun-Hyung> <https://research.tib.eu/covid-19/entity/Martin_Lindsay> <https://research.tib.eu/covid-19/entity/Sexton_Mary_Elizabeth> <https://research.tib.eu/covid-19/entity/Shih_Jennifer> <https://research.tib.eu/covid-19/entity/Vanijcharoenkarn_Kristine>
?:doi	10.1093/cid/ciab448
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/cid/ciab448>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33989390>
?:pmid	<https://research.tib.eu/covid-19/entity/33989390>
?:pmid	33989390
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33989390>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33989390>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all